|

SHR-A2102；Adebrelimab Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2/3: 1

Top Sponsors

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd.1

Indications

  • Muscular Invasive Bladder Cancer (MIBC)1
  • Cancer1

Other1 trial

Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.